BRK-B vs OXBR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
OXBR exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows strong top-line revenue growth of 36.5%, this is completely offset by catastrophic profitability, with a profit margin of -80.68% and an ROE of -41.19%. The stock is in a clear technical downtrend, losing over 51% of its value in the last year, and consistently misses earnings estimates by wide margins. Trading at a P/B of 0.95 suggests the market is pricing in the ongoing erosion of the company's book value.
Compare Another Pair
Related Comparisons
BRK-B vs OXBR: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Oxbridge Re Holdings Limited (OXBR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.